- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 215/12 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
Patent holdings for IPC class C07D 215/12
Total number of patents in this class: 475
10-year publication summary
29
|
25
|
26
|
25
|
41
|
24
|
32
|
21
|
19
|
8
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Merck Patent GmbH | 5909 |
12 |
Bristol-myers Squibb Company | 5080 |
11 |
Janssen Pharmaceutica N.V. | 3839 |
11 |
Sun Pharma Advanced Research Company Ltd. | 197 |
7 |
Ohio State Innovation Foundation | 1770 |
6 |
Hendrix College | 15 |
6 |
The Regents of the University of California | 18943 |
5 |
Life Technologies Corporation | 3068 |
5 |
The Scripps Research Institute | 1364 |
5 |
VALO Health, Inc. | 147 |
5 |
Shaanxi Lighte Optoelectronics Material Co., Ltd. | 190 |
5 |
Novartis AG | 11238 |
4 |
Samsung Display Co., Ltd. | 30585 |
4 |
Boehringer Ingelheim International GmbH | 4629 |
4 |
Massachusetts Institute of Technology | 9795 |
4 |
Toray Industries, Inc. | 6652 |
4 |
Katholieke Universiteit Leuven | 1035 |
4 |
Agc, Inc. | 4029 |
4 |
SpringWorks Therapeutics, Inc. | 83 |
4 |
The Royal Institution for The Advancement of Learning / McGill University | 622 |
4 |
Other owners | 361 |